Loading...
 
Back to the list
Mediterr J Rheumatol 2019;30(Supp 1):82-3
Article Links
2018 Position Paper on Biosimilars of the Greek Rheumatology Society and Professional Association of Greek Rheumatologists
Dimos Patrikos1, Kyriaki Boki2, Dimitrios Boumpas3, Dimitrios Vassilopoulos4
Authors Information

1Rheumatology Unit, Metropolitan Hospital, Piraeus, Greece

2Rheumatology Unit, Sismanoglio Hospital, Athens, Greece

3National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece

4Joint Rheumatology Program, Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital

Keywords: Position, biosimilars, rheumatology
References
  1. 2015 Position Paper on Biosimilars of the Greek Rheumatology Society and Professional Association of Greek Rheumatologists. Available at: http://www.ere.gr/1097  
  2. Kay J, Schoels MM, Dorner T, Emery P, Kvien TK, Smolen JS, et al. Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. Ann Rheum Dis 2018;77:165-74. [https://doi.org/10.1136/annrheumdis-2017-211937] [PMID: 28866648]
  3. Bridges SL, Jr., White DW, Worthing AB, Gravallese EM, O'Dell JR, Nola K, et al. The Science Behind Biosimilars: Entering a New Era of Biologic Therapy. Arthritis Rheumatol 2018;70:334-44. [https://doi.org/10.1002/art.40388] [PMID: 29411547]
  4. British Society for Rheumatology Position statement on biosimilar medicines. Available  at: http://www.nras.org.uk/data/files/revised_bsr_biosimilars_position_statement_jan_2017.pdf